耐多药结核病及其与COVID-19的关系

A. K. Chhillar, Jasmine Arya, Sweety Dahiya
{"title":"耐多药结核病及其与COVID-19的关系","authors":"A. K. Chhillar, Jasmine Arya, Sweety Dahiya","doi":"10.2174/2666796704666230822113632","DOIUrl":null,"url":null,"abstract":"\n\nMycobacterium tuberculosis is the leading cause of death due to pulmonary diseases and has developed resistance to various antibiotics over time making it extremely difficult to treat and eradicate. For an effective treatment regime, it becomes necessary to understand the factors and mechanisms of resistance to predict the possibility of associated resistance. In the present-day scenario, conditions of Tuberculosis patients have worsened due to COVID-19 with escalated mortality rates. Additionally, COVID-19 has also affected the regime and regular monitoring of patients which is mainly because of the shift in the focus and toxicity of various COVID-19 and Tuberculosis drug combinations.\n","PeriodicalId":10815,"journal":{"name":"Coronaviruses","volume":"40 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Multidrug-resistant Tuberculosis and its Implication with COVID-19\",\"authors\":\"A. K. Chhillar, Jasmine Arya, Sweety Dahiya\",\"doi\":\"10.2174/2666796704666230822113632\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n\\nMycobacterium tuberculosis is the leading cause of death due to pulmonary diseases and has developed resistance to various antibiotics over time making it extremely difficult to treat and eradicate. For an effective treatment regime, it becomes necessary to understand the factors and mechanisms of resistance to predict the possibility of associated resistance. In the present-day scenario, conditions of Tuberculosis patients have worsened due to COVID-19 with escalated mortality rates. Additionally, COVID-19 has also affected the regime and regular monitoring of patients which is mainly because of the shift in the focus and toxicity of various COVID-19 and Tuberculosis drug combinations.\\n\",\"PeriodicalId\":10815,\"journal\":{\"name\":\"Coronaviruses\",\"volume\":\"40 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-08-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Coronaviruses\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/2666796704666230822113632\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Coronaviruses","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/2666796704666230822113632","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

结核分枝杆菌是肺部疾病导致死亡的主要原因,随着时间的推移,它对各种抗生素产生了耐药性,使其极难治疗和根除。为了制定有效的治疗方案,有必要了解耐药的因素和机制,以预测相关耐药的可能性。在目前的情况下,由于COVID-19,结核病患者的病情恶化,死亡率上升。此外,COVID-19还影响了患者的治疗方案和定期监测,这主要是由于各种COVID-19和结核病药物组合的重点和毒性发生了变化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Multidrug-resistant Tuberculosis and its Implication with COVID-19
Mycobacterium tuberculosis is the leading cause of death due to pulmonary diseases and has developed resistance to various antibiotics over time making it extremely difficult to treat and eradicate. For an effective treatment regime, it becomes necessary to understand the factors and mechanisms of resistance to predict the possibility of associated resistance. In the present-day scenario, conditions of Tuberculosis patients have worsened due to COVID-19 with escalated mortality rates. Additionally, COVID-19 has also affected the regime and regular monitoring of patients which is mainly because of the shift in the focus and toxicity of various COVID-19 and Tuberculosis drug combinations.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.50
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信